Peptide research index
59 compounds, ranked by how much indexed research references them. Every page links back to the underlying publications. Reference only, not guidance.
Multiple / unspecified peptide bioregulators
86 publications · 6 human studies
1982–2023
Epitalon (AEDG)
48 publications · 1 human studies
2000–2026
Vilon (KE)
22 publications · 1 human studies
2000–2023
Semax
21 publications · 5 human studies
1997–2026
Epithalamin
15 publications · 4 human studies
1992–2012
Cortexin
14 publications · 8 human studies
1999–2026
Selank
13 publications · 4 human studies
2001–2022
Pancragen (KEDW-NH2)
11 publications · 1 human studies
2005–2021
Pinealon (EDR)
10 publications · 0 human studies
2008–2021
Retinalamin
10 publications · 7 human studies
2000–2024
Dalargin
10 publications · 1 human studies
1985–2021
Prostatilen / Samprost
9 publications · 6 human studies
1991–2026
Thymogen (EW)
9 publications · 2 human studies
1997–2024
Noopept / Omberacetam
9 publications · 2 human studies
2002–2019
Dilept / GZR-123
8 publications · 0 human studies
1999–2014
Alloferon-1 / Allokin alpha
8 publications · 0 human studies
2008–2022
Thymalin
7 publications · 4 human studies
1985–2023
Bronchogen (AEDL)
7 publications · 0 human studies
2011–2021
Vesugen (KED)
7 publications · 0 human studies
2010–2021
Immunofan / Imunofan
6 publications · 1 human studies
1999–2025
Licopid / GMDP
6 publications · 5 human studies
1999–2020
Brain peptide / cytomedine complex (unspecified)
6 publications · 0 human studies
1996–2018
Bestim / SCV-07 / Golotimod
6 publications · 3 human studies · 4 trials
2003–2011
Delta sleep-inducing peptide (DSIP)
5 publications · 0 human studies
2003–2009
Pineal peptide complex (unspecified)
5 publications · 0 human studies
1979–2005
EDL tripeptide
4 publications · 0 human studies
2017–2021
Thymodepressin
4 publications · 2 human studies
2002–2021
Tactivin
4 publications · 3 human studies
1994–2009
Cellex
4 publications · 4 human studies
2014–2018
Gepon / HEP-1
4 publications · 1 human studies · 2 trials
2003–2021
Ac-HAEE-NH2
3 publications · 0 human studies
2015–2021
AED tripeptide
3 publications · 0 human studies
2019–2021
Myelopid
3 publications · 0 human studies
2009–2021
Thymic peptide complex (unspecified)
3 publications · 0 human studies
1982–1997
EDA tripeptide
2 publications · 0 human studies
2020–2021
DS dipeptide
2 publications · 0 human studies
2020–2021
Stemokin
2 publications · 0 human studies
2016–2022
Deltaran
2 publications · 0 human studies
2008–2009
Myelopeptide MP-1
2 publications · 0 human studies
2013–2021
AAAAEK repeat peptide
2 publications · 0 human studies
2020–2021
CP-88
2 publications · 0 human studies
2016–2024
Cortagen (AEDP)
2 publications · 0 human studies
2000–2004
Vascular peptide bioregulator (unspecified)
2 publications · 0 human studies
2016–2018
Pineamin
2 publications · 1 human studies
2017–2017
Myelopeptide MP-5
2 publications · 0 human studies
2009–2021
Retinal peptide complex (unspecified)
2 publications · 0 human studies
2002–2003
KEDG tetrapeptide
2 publications · 0 human studies
2020–2021
Myelopeptide MP-6
1 publications · 0 human studies
2021–2021
Myelopeptide MP-2
1 publications · 0 human studies
2021–2021
Livagen (KEDA)
1 publications · 1 human studies
2002–2002
Leytragin
1 publications · 0 human studies
2021–2021
Pituitary peptide complex (unspecified)
1 publications · 1 human studies
2011–2011
Pro-Gly-Pro (PGP)
1 publications · 0 human studies
2011–2011
RADD peptide
1 publications · 0 human studies
2015–2015
RepG3
1 publications · 0 human studies
2021–2021
EDP tripeptide
1 publications · 0 human studies
2019–2019
Cyclo-L-prolylglycine (cPG)
1 publications · 0 human studies
2002–2002
Cardiogen (AEDR)
1 publications · 0 human studies
2012–2012
Allostatin-1
1 publications · 0 human studies
2011–2011